These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31743472)

  • 1. An LC-MS/MS method for determination of O
    Mannem C; Xu Y
    Biomed Chromatogr; 2020 Feb; 34(2):e4750. PubMed ID: 31743472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
    Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
    Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of O(6)-alkylguanine-DNA alkyltransferase activity in tumour cells using stable isotope dilution HPLC-ESI-MS/MS.
    Sun G; Zhao L; Fan T; Ren T; Zhong R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():138-146. PubMed ID: 27544051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
    Stefan TL; Ingalls ST; Minkler PE; Willson JK; Gerson SL; Spiro TP; Hoppel CL
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):289-98. PubMed ID: 9518162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
    Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ
    Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
    Long L; Berg SL; Roy SK; McCully CL; Song-Yoo HW; Moschel RC; Balis FM; Dolan ME
    Clin Cancer Res; 2000 Sep; 6(9):3662-9. PubMed ID: 10999759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
    Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
    Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
    Friedman HS; Pluda J; Quinn JA; Ewesuedo RB; Long L; Friedman AH; Cokgor I; Colvin OM; Haglund MM; Ashley DM; Rich JN; Sampson J; Pegg AE; Moschel RC; McLendon RE; Provenzale JM; Stewart ES; Tourt-Uhlig S; Garcia-Turner AM; Herndon JE; Bigner DD; Dolan ME
    J Clin Oncol; 2000 Oct; 18(20):3522-8. PubMed ID: 11032594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
    Ewesuedo RB; Wilson LR; Friedman HS; Moschel RC; Dolan ME
    Cancer Chemother Pharmacol; 2001; 47(1):63-9. PubMed ID: 11221964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral O6-benzylguanine and evidence of interaction with oral ketoconazole in the rat.
    Ewesuedo RB; Dolan ME
    Cancer Chemother Pharmacol; 2000; 46(2):150-5. PubMed ID: 10972485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
    Neville K; Blaney S; Bernstein M; Thompson P; Adams D; Aleksic A; Berg S
    Clin Cancer Res; 2004 Aug; 10(15):5072-5. PubMed ID: 15297409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the conserved residue tyrosine-158 to histidine renders human O6-alkylguanine-DNA alkyltransferase insensitive to the inhibitor O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Pegg AE
    Cancer Res; 1999 Apr; 59(7):1514-9. PubMed ID: 10197622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved residue lysine165 is essential for the ability of O6-alkylguanine-DNA alkyltransferase to react with O6-benzylguanine.
    Xu-Welliver M; Kanugula S; Loktionova NA; Crone TM; Pegg AE
    Biochem J; 2000 Apr; 347(Pt 2):527-34. PubMed ID: 10749683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
    Cai Y; Wu MH; Xu-Welliver M; Pegg AE; Ludeman SM; Dolan ME
    Cancer Res; 2000 Oct; 60(19):5464-9. PubMed ID: 11034089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial.
    Weingart J; Grossman SA; Carson KA; Fisher JD; Delaney SM; Rosenblum ML; Olivi A; Judy K; Tatter SB; Dolan ME
    J Clin Oncol; 2007 Feb; 25(4):399-404. PubMed ID: 17264335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
    Long L; McCabe DR; Dolan ME
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):241-9. PubMed ID: 10510777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.
    Wu MH; Lohrbach KE; Olopade OI; Kokkinakis DM; Friedman HS; Dolan ME
    Clin Cancer Res; 1999 Jan; 5(1):209-13. PubMed ID: 9918221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations on the effect of O(6)-benzylguanine on the formation of dG-dC interstrand cross-links induced by chloroethylnitrosoureas in human glioma cells using stable isotope dilution high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
    Sun G; Zhao L; Fan T; Li S; Zhong R
    Chem Res Toxicol; 2014 Jul; 27(7):1253-62. PubMed ID: 24914620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of codon 160 in the sensitivity of human O6-alkylguanine-DNA alkyltransferase to O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Meehan WJ; Pegg AE
    Biochem Pharmacol; 1999 Oct; 58(8):1279-85. PubMed ID: 10487529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.